Safe (ALSAF.PA) Stock Price

Safe Price

Euronext·CLOSED
0.64
​
Market closed

Over the last 12 years Safe grew revenue by 25.5% annually, reaching 5.04 M EUR. For Safe, the net margin of -38,272.6% is down versus -227.1% a few years ago. The consensus 12-month price target for Safe is 0.33 EUR, about 49.0% below where the stock trades today. Of 7 analysts, 0 rate the stock a buy — an overall Sell consensus.

Safe stock price

Access this data via the Eulerpool API

Safe business model & stock analysis

Safe Orthopaedics SAS engages in the development, production and commercialization of spinal surgery products. The company is headquartered in Eragny, Ile-De-France and currently employs 43 full-time employees. The company went IPO on 2015-02-10. The firm focuses on the development and commercialization of products for use in spinal surgery. The company provides a range of implants and ready to use instrument kits. The firm's product portfolio comprises SteriSpine PS, which is the Pedicle Screw System; and SteriSpine LC, which is the Lumbar Cage System that enables safe implant positioning, as well as access, insertion and placement of the implant. The firm's products are equipped with quick change handle, dual trial and impact removal, among others. The firm mainly uses polyarylamid material, which is a polymar with 50% glass fibers.

Frequently asked questions about Safe

Analysts currently set an average price target of 0.33 EUR for the Safe stock (median: 0.33 EUR), implying -49.0 % versus the latest price. The consensus is based on 7 analyst ratings.

7 analysts currently rate the Safe stock: 0 recommend buying, 3 holding and 4 selling. For 2026, analysts expect Safe to generate revenue of 15.60 M EUR and earnings per share of -0.08 EUR.

The Safe share (ALSAF.PA) is listed on 5 stock exchanges, including: London (0RAA.L), Frankfurt (OR9A.F), München (OR9A.MU), Paris (ALSAF.PA).

The expected revenue of Safe is 15.60 M EUR. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Safe is -598.46 EUR. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Safe is currently -8.23. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Safe stock.

The price-to-sales ratio (P/S) of Safe is currently 0.00. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Safe stock.

The Eulerpool Quality Score for Safe is 3/10.

The ISIN of Safe is FR001400ZU25. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Safe is A2PW9B. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Safe is ALSAF.PA. The ticker symbol is used to trade Safe shares on the stock exchange.

Fair ValueTerminal
0.54 EUR
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue per Employee
117,232.56 EUR
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Currency
EUR
Initial public offering
Feb 10, 2015
ISIN
FR001400ZU25
Cusip
F7987L125
Sedol
BJQTS76
Market capitalization
4,928.00 EURMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2025
-0.00
P/Ee 2026
-8.23
P/S
P/Se
0.00
EV/EBIT
—
P/B Ratio
0.01
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-57,317.97 %
Last updated Oct 10, 2026, 1:59 PM

Safe Ticker

EURONEXT · ALSAF.PAFRANKFURT · OR9A.FLONDON · 0RAA.LMUNICH · OR9A.MUPARIS · ALSAF.PA

All fundamentals and in-depth analysis of Safe

Our stock analysis for Safe stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Safe. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.